FDA warns of ‘unnecessary risk’ as AmEx pulls lots of Avastin over sterility concerns
The US FDA has followed up a public recall request to AmEx by hosting the manufacturer’s notice of a voluntary recall of Avastin, after sterility concerns.
Archives for September 3, 2019
Genome editing allows for ‘faster, simpler’ CHO cell lines
As MilliporeSigma expands its patent portfolio for its genome editing technology, the company’s head of strategy discusses how CRISPR is changing the bioproduction landscape.
iBio and CC-Pharming to launch plant-based rituximab in China
iBio grants CC-Pharming exclusive license to commercialize rituximab in China, as well as a research license to bring its FastPharming technology to the country.
Samsung BioLogics’ perfusion technology to ‘reduce production time by up to 30%’
Samsung BioLogics announces adoption of perfusion technology with alternating tangential flow for the commercial bioproduction process.
908 Devices launches a Rebel-lion in media analyzing
908 Devices launches Rebel, a bioprocess analyzer, enabling researchers to conduct their own cell culture media analysis to accelerate process development ‘by weeks’.
Massachusetts bioproduction employment outpaces national average
Biopharma employment levels in the state of have Massachusetts grown at a rate of 6% since 2009, bettering the national average of 1%.
Innovate UK provides grant for cell therapy preservation hydrogel
Atelerix to work on the development of gel stabilisation technologies enabling room temperature storage of Rexgenero’s cell therapy candidate, under an Innovate UK grant.